insulinotropic hormone secretion peptide fusion protein(Lanzhou Institute of Biological Products)
促胰岛素分泌肽融合蛋白（兰州生物制品研究所）
Report date: 2023/12/08 15:57:22
Base Information
Drug Nameinsulinotropic hormone secretion peptide fusion protein(Lanzhou Institute of Biological Products)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesLanzhou Institute Of Biological Products Co Ltd
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Active CompaniesLanzhou Institute Of Biological Products Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A